| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 04/04/2007 | CN1308029C Application of Chinese ginger extract in preparation of fatty acid synthetase inhibitor |
| 04/04/2007 | CN1308024C Medicine for treating diabetes and its preparing method |
| 04/04/2007 | CN1308011C Method for extracting ganoderma lucidum spore fat soluble active substance |
| 04/04/2007 | CN1307996C Composition for treating hyperlipemia |
| 04/04/2007 | CN1307993C Macrolides-containing pharmaceutical compositions |
| 04/04/2007 | CN1307990C Triglyceride depressant composition |
| 04/04/2007 | CN1307989C Use of phytanic acid for treating diabetes |
| 04/04/2007 | CN1307988C Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
| 04/04/2007 | CN1307983C Mai-an dripping pill for treating hyperlipoproteinemia and its preparing method |
| 04/04/2007 | CN1307982C Maishu dripping pill for reducing blood fat and its preparing method |
| 04/04/2007 | CN1307981C Xuening dripping pill having hemostatic function and its preparing method |
| 04/04/2007 | CN1307909C Technological process for preparing beverage, oral liquor, granule, and antitoxic tablet from fern root |
| 04/04/2007 | CN1307903C Fruit/vegetable coarse fibre composition and processing method and application thereof |
| 04/03/2007 | US7199265 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
| 04/03/2007 | US7199243 Antilipemic agents; anticholesterol agents; atherosclerosis; cardiovascular disorders; obesity; antidiabetic agents |
| 04/03/2007 | US7199239 Chemical compounds |
| 04/03/2007 | US7199219 Polypeptides derived from vitamin D nuclear receptor, and their uses in particular for screening vitamin D analogues |
| 04/03/2007 | US7199160 Antiobestic agents and health foods |
| 04/03/2007 | US7199159 Use of biguanide derivatives for making a medicine having a wound healing effect |
| 04/03/2007 | US7199150 Amino alcohol compounds |
| 04/03/2007 | US7199145 Derivatives of hydantoins, thiohydantoins, pyrimidinediones and thioxopyrimidinones, their preparation processes and their use as medicaments |
| 04/03/2007 | US7199142 1-((5-aryl-1,2,4-oxadiazol-3-yl) benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl) pyrrolidine-3-carboxylates as edg receptor agonists |
| 04/03/2007 | US7199140 (bis(Phenoxy or phenylsulfonamido)phenylethyl)pyridyl carboxylic acids, esters or amides; antidiabetic agents; obesity; glucokinase agonists |
| 04/03/2007 | US7199139 Medicinal compositions containing diuretic and insulin resistance-improving agent |
| 04/03/2007 | US7199130 Substituted 5,6,6a, 11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid compounds as NMDA-antagonists |
| 04/03/2007 | US7199121 Protein tyrosine phosphatase inhibitor |
| 04/03/2007 | US7199116 Administering 7-oxo-dehydroepiandrosterone (DHEA) or prodrug incapable of in vivo conversion to testosterone |
| 04/03/2007 | US7198913 Nucleotide sequences coding polypeptide for use in the treatment of apoptosis, inflammatory and autoimmune disorders |
| 04/03/2007 | US7198910 Nucleic acid encoding melanin-concentrating hormone receptor |
| 04/03/2007 | US7198254 System for producing micro-cluster liquids |
| 04/03/2007 | CA2419573C Method of increasing testosterone and related steroid concentrations in women |
| 04/03/2007 | CA2388452C Oxa- and thiazole derivatives useful as antidiabetic and antiobesity agents |
| 04/03/2007 | CA2344053C Composition containing cinnamic acid derivatives for preventing or treating elevated blood lipid level-related diseases |
| 04/03/2007 | CA2276459C Novel method for testing the differentiation status in pancreatic cells of a mammal |
| 04/03/2007 | CA2236269C Selective .beta.3 adrenergic agonists |
| 04/03/2007 | CA2205275C Vitamin d3 analogs |
| 04/03/2007 | CA2176510C Method for preparing concentrated biologically active silicon compounds |
| 03/29/2007 | WO2007035945A1 Tetrahydro-cyclopentyl pyrazole cannabinoid modulators |
| 03/29/2007 | WO2007035784A1 Vitamin d derivatives for the treatment of type i diabetes |
| 03/29/2007 | WO2007035759A1 Modulation of glucocorticoid receptor expression |
| 03/29/2007 | WO2007035703A1 1- [ [1- [ (2-amin0-6-methyl-4-pyridinyl) methyl] -4-flu0r0-4-piperidinyl,] carbonyl] -4- [2- (2-pyridinyl) -3h-imidaz0 [4 , 5-b] pyridin-3-yl] piperidine useful as histamine h3 antagonist |
| 03/29/2007 | WO2007035496A1 Tail variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers |
| 03/29/2007 | WO2007035372A2 Polymorphs of benzoate salt of 2-[[6-[(3r)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2h)-pyrimidinyl]methyl]-benzonitrile and methods of use therefor |
| 03/29/2007 | WO2007035367A1 Northern white kidney bean extract and red kidney bean extract in combination with green tea extract in the treatment of obesity |
| 03/29/2007 | WO2007034910A1 Medicinal composition for treating bulimia and depression accompanying bulimia |
| 03/29/2007 | WO2007034851A1 Visceral fat accumulation inhibitor |
| 03/29/2007 | WO2007034807A1 Dipeptide-containing composition for oral administration |
| 03/29/2007 | WO2007034778A1 Prophylactic/therapeutic agent for sleep disorder |
| 03/29/2007 | WO2007034401A1 Amino acid and its uses |
| 03/29/2007 | WO2007034316A1 Process for annealing amorphous atorvastatin |
| 03/29/2007 | WO2007012661A8 Hydantoin derived compounds and use thereof as mchr-1 antagonists |
| 03/29/2007 | WO2007010337A3 Use of phosphodiesterase type 5 inhibitors for the prevention and treatment of diseases or health disorders and dispensing system for said inhibitors |
| 03/29/2007 | WO2007009721A3 Indoline-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 03/29/2007 | WO2007004878A3 Infant nutrition with hydrolised proteins |
| 03/29/2007 | WO2006125181A3 Piperidine derivatives and their use as stearoyl-coa desaturase modulators |
| 03/29/2007 | WO2006117761A3 Magnesium salts of hmg-coa reductase inhibitors |
| 03/29/2007 | WO2006108965A3 Npy antagonists, preparation and use |
| 03/29/2007 | WO2006097074A3 Medicament consisting of plant extracts as a lipase inhibitor |
| 03/29/2007 | US20070073040 Anti-obesity polypeptides |
| 03/29/2007 | US20070072942 Statin derivatives |
| 03/29/2007 | US20070072932 Use of tyrosine kinase inhibitor to treat diabetes |
| 03/29/2007 | US20070072916 Amino ceramide-like compounds and therapeutic methods of use |
| 03/29/2007 | US20070072907 Use of a pyrazole derivative for preparing medicinal products that are useful in the prevention and treatment of dyslipidaemias and of diseases related to dyslipidaemias and/or to obesity |
| 03/29/2007 | US20070072865 Bicyclic piperazine compound and use thereof |
| 03/29/2007 | US20070072844 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 03/29/2007 | US20070072814 Method and means of modulating lipid metabolism |
| 03/29/2007 | US20070072812 Quaternary salt derivatives of 1,4-diphenylazetidin-2-ones |
| 03/29/2007 | US20070072810 Agent for treating diabetes |
| 03/29/2007 | US20070072801 Methods of treatment using specific binding agents of human angiopoietin-2 |
| 03/29/2007 | US20070072236 Novel type II Na/Pi cotransporters and type II Na/Pi cotransporter expression regulatory factors |
| 03/29/2007 | US20070071812 Pharmaceutical composition containing fenofibrate and method for the preparation thereof |
| 03/29/2007 | US20070071794 Drugs for treating diabetes |
| 03/29/2007 | US20070071730 Stem cells of the islets of langerhans and their use in treating diabetes mellitus |
| 03/29/2007 | DE102005046258A1 Immunosorbent for treating insulin resistance or metabolic syndrome comprises a polymeric support to which are attached ligands that specifically bind to interleukin-6 |
| 03/29/2007 | DE10125882B4 Arzneimittel enthaltend Ambroxol, dessen Salze und/oder Prodrugs zusammen mit α-Liponsäure im Rahmen der Behandlung des Diabetes mellitus Medicament comprising ambroxol, its salts and / or prodrugs together with α-lipoic acid in the context of the treatment of diabetes mellitus |
| 03/29/2007 | CA2624420A1 Vitamin d derivatives for the treatment of type i diabetes |
| 03/29/2007 | CA2623803A1 Tetrahydro-cyclopentyl pyrazole cannabinoid modulators |
| 03/29/2007 | CA2623772A1 Modulation of glucocorticoid receptor expression |
| 03/29/2007 | CA2623025A1 1- [ [1- [ (2-amin0-6-methyl-4-pyridinyl) methyl] -4-flu0r0-4-piperidinyl,] carbonyl] -4- [2- (2-pyridinyl) -3h-imidaz0 [4 , 5-b] pyridin-3-yl] piperidine useful as histamine h3 antagonist |
| 03/29/2007 | CA2622698A1 Polymorphs of benzoate salt of 2-[[6-[(3r)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2h)-pyrimidinyl]methyl]-benzonitrile and methods of use therefor |
| 03/29/2007 | CA2622523A1 Tail variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers |
| 03/28/2007 | EP1767650A1 Method of screening compound directly activating glycogen synthase |
| 03/28/2007 | EP1767638A2 Mutation associated with epilepsy |
| 03/28/2007 | EP1767637A1 Mutation associated with epilepsy |
| 03/28/2007 | EP1767632A2 A method for local administration of synthetic double-stranded oligonucleotides targeting a VEGF receptor |
| 03/28/2007 | EP1767544A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin - 2 |
| 03/28/2007 | EP1767534A1 Drug for treating or preventing duplication of hypertension with serum hyperuricemia and/or hypercholesterolemia |
| 03/28/2007 | EP1767525A1 Guanidino compounds as melanocortin-4 receptor (MC4-R) agonists |
| 03/28/2007 | EP1767215A1 Isoflavones against radiation-induced mortality |
| 03/28/2007 | EP1767209A1 Neuroprotective drug |
| 03/28/2007 | EP1767207A2 Solid Oral Dosage Forms |
| 03/28/2007 | EP1767206A2 Solid Oral Dosage Forms |
| 03/28/2007 | EP1767205A1 Lipase inhibitors |
| 03/28/2007 | EP1767204A1 Lipase inhibitors |
| 03/28/2007 | EP1767203A1 Fat combustion accelerator |
| 03/28/2007 | EP1767201A1 Nutrient composition and composition for prevention/mitigation of digestive tract depression |
| 03/28/2007 | EP1767198A1 Regulator of physiological function of ghrelin and use thereof |
| 03/28/2007 | EP1765991A1 Acetyl coa carboxylase splice variant and uses thereof |
| 03/28/2007 | EP1765873A1 Methods and compositions using cd3 agonists |
| 03/28/2007 | EP1765796A1 Substituted heteroaryl- and phenylsulfamoyl compounds |